Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?

To: mac 1 who wrote (33148)	2/23/1999 2:22:00 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 34592

They have a lock on virtually all of the IL-1beta patents. Mostly, they're just a big bank account. The patents are useful, and should lead to adjuvant work for "genetic vaccines". Two years ago, I valued the patents at $40 million. The CEO has managed the company into the ground, IMO, but.... cash and patents, it's still a huge bargain and candidate for acquisition or reverser merge. I now value the patents at about $15 million. Placing a value on biotech patents is a highly personal and variable activity. ;-)